A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
Zacks.com on MSN6d
CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With TevaShares of Catalyst Pharmaceuticals CPRX gained 16.7% on Wednesday after the company, along with its licensor, SERB, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback